They showed that high TGFB2 mRNA levels were associated with an immunologically “cold” tumor microenvironment (TME), characterized by low expression of antigen-presenting cell (APC) markers (e.g., CD14, CD163, ITGAX/CD11c), which impairs anti-tumor immune responses [10]. The gene discussed is CD14; the disease is neoplasm.